Abstract
We aimed (i) to gain a better understanding of the demographic and socioeconomical distribution of ADHD risk in Sweden; and (ii) to contribute to the critical discussion on medicalization, i.e., the tendency to define and treat behavioural and social problems as medical entities. For this purpose, we analysed the risk of suffering from ADHD in the whole Swedish population aged between 5 and 60 years, across 96 different strata defined by combining categories of gender, age, income, and country of birth. The stratified analysis evidenced considerable risk heterogeneity, with prevalence values ranging from 0.03% in high income immigrant women aged 50–59, to 6.18% in middle income immigrant boys aged 10–14. Our study questions the established idea that behavioural difficulties conceptualized as ADHD should be primarily perceived as a neurological abnormality. Rather, our findings suggest that there is a strong sociological component behind how some individuals become impaired and subject to medicalization.
Publisher
Public Library of Science (PLoS)
Reference86 articles.
1. Moderaterna. (2022, 12 aug). Förslag: Snabbtest för ADHD i utsatta områden. https://moderaterna.se/stockholm/nyhet/forslag-snabbtest-for-adhd-i-utsatta-omraden/
2. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis;R. Thomas;Pediatrics,2015
3. National Board of Health and Welfare. (2019). Welfare SNBoHa. Statistical databases. https://www.socialstyrelsen.se/en/statistics-and-data/statistics/statistical-databases/
4. Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden—a longitudinal population-based register study;M. Polyzoi;Neuropsychiatric disease and treatment,2018
5. The World Federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder;S. V. Faraone;Neuroscience and biobehavioral reviews,2021